Longeveron Inc(LGVN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LGVN Longeveron Inc

Market Closed 08-07 16:00:00 EDT

0.7660

-0.0075

-0.97%

盘后0.7800

+0.0140+1.83%

19:58 EDT

High0.8000	Low0.7501	Vol417.75K
Open0.7770	D1 Closing0.7735	Amplitude6.45%
Mkt Cap24.20M	Tradable Cap20.88M	Total Shares31.60M
T/O323.96K	T/O Rate1.53%	Tradable Shares27.26M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LGVN","market":"US","secType":"STK","nameCN":"Longeveron Inc","latestPrice":0.766,"timestamp":1786132800000,"preClose":0.7735,"halted":0,"volume":417747,"hourTrading":{"tag":"盘后","latestPrice":0.78,"preClose":0.766,"latestTime":"19:58 EDT","volume":10941,"amount":8528.9268,"timestamp":1786147089643,"change":0.014,"changeRate":0.018277,"amplitude":0.018277},"delay":0,"changeRate":-0.00969618616677434,"floatShares":27255300,"shares":31597952,"eps":-1.119466,"marketStatus":"Market Closed","change":-0.0075,"latestTime":"08-07 16:00:00 EDT","open":0.777,"high":0.8,"low":0.7501,"amount":323957.39703129,"amplitude":0.064512,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.119466,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1786348800000},"marketStatusCode":7,"adr":0,"listingDate":1613106000000,"exchange":"NASDAQ","adjPreClose":0.7735,"preHourTrading":{"tag":"盘前","latestPrice":0.78,"preClose":0.7735,"latestTime":"09:15 EDT","volume":68,"amount":53.387996799999996,"timestamp":1786108504123,"change":0.0065,"changeRate":0.008403,"amplitude":0.052489},"postHourTrading":{"tag":"盘后","latestPrice":0.78,"preClose":0.766,"latestTime":"19:58 EDT","volume":10941,"amount":8528.9268,"timestamp":1786147089643,"change":0.014,"changeRate":0.018277,"amplitude":0.018277},"volumeRatio":0.960582},"requestUrl":"/m/hq/s/LGVN/tweets","defaultTab":"tweets","newsList":[{"id":"2656301657","title":"Longeveron Schedules Q2 Financial Results, Business Update Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2656301657","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656301657?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:07","pubTimestamp":1785787636,"startTime":"0","endTime":"0","summary":"Longeveron schedules Q2 financial results, business update conference callLongeveron will report 2026 Q2 financial results on Aug. 12, 2026, following the U.S. market close.A conference call, webcast ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDLc471Zg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BN0W2T93.GBP","SG9999014005.SGD","LU0314104364.USD","LU2210149790.SGD","LU2210150020.SGD","SG9999014013.SGD","SG9999014039.USD","BK4139","BCDF","IE00B3QW5Z07.USD","NDAQ","IE00BGHQF748.EUR","BK4588","IE00BKPKM429.USD","IE00BN0W2W23.USD","SG9999014021.USD","IE00BN0W2V16.EUR","BK4585","LGVN","BK4112","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656307853","title":"Longeveron to Report 2026 Second Quarter Financial Results and Host Conference Call on August 12, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2656307853","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656307853?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:05","pubTimestamp":1785787500,"startTime":"0","endTime":"0","summary":"MIAMI, Fla., Aug.  03, 2026  (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/03/3337863/0/en/Longeveron-to-Report-2026-Second-Quarter-Financial-Results-and-Host-Conference-Call-on-August-12-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LGVN","BK4181","MSC","BK4585","BK4575","BK4150","HST","BK4218","BK4139","BK4132","AD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655816137","title":"Longeveron Regains NASDAQ Audit Committee Compliance After Board Reshuffle","url":"https://stock-news.laohu8.com/highlight/detail?id=2655816137","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655816137?lang=en_us&edition=fundamental","pubTime":"2026-07-30 04:13","pubTimestamp":1785356038,"startTime":"0","endTime":"0","summary":"Longeveron regains Nasdaq audit committee compliance after board reshuffleLongeveron regained compliance with Nasdaq audit committee rules following a board reshuffle finalized at a July 24, 2026 meet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDLbsS59t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653723983","title":"Longeveron Elects Deborah Ascheim to Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2653723983","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653723983?lang=en_us&edition=fundamental","pubTime":"2026-07-23 21:15","pubTimestamp":1784812523,"startTime":"0","endTime":"0","summary":"Longeveron elects Deborah Ascheim to board of directorsDeborah D. Ascheim, M.D., elected to the board on July 23, 2026.Ascheim is fractional chief medical officer at Rejuvenate Bio.Previously chief me","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL88y06H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","IE00BGHQF748.EUR","NDAQ","IE00BN0W2W23.USD","IE00BKPKM429.USD","LU0314104364.USD","IE00BN0W2V16.EUR","SG9999014021.USD","SG9999014039.USD","SG9999014013.SGD","CAPR","BK4585","LGVN","BCDF","SG9999014005.SGD","BK4588","LU2210150020.SGD","BK4112","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","LU2210149790.SGD","IE00BN0W2T93.GBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653236267","title":"Deborah D. Ascheim, M.d. Elected to Longeveron Board of Directors","url":"https://stock-news.laohu8.com/highlight/detail?id=2653236267","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653236267?lang=en_us&edition=fundamental","pubTime":"2026-07-23 21:15","pubTimestamp":1784812500,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nTUA7FZX1K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653378623","title":"Longeveron CFO Marie Washburn Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2653378623","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653378623?lang=en_us&edition=fundamental","pubTime":"2026-07-22 06:00","pubTimestamp":1784671245,"startTime":"0","endTime":"0","summary":"Longeveron CFO Marie Washburn files initial beneficial ownership statementLongeveron CFO Marie Washburn reported direct ownership of 101,030 Class A common shares in an initial Form 3 dated July 13, 2","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nNDL13nl5X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651445831","title":"Longeveron Enhances CEO Compensation and Retention Protections","url":"https://stock-news.laohu8.com/highlight/detail?id=2651445831","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651445831?lang=en_us&edition=fundamental","pubTime":"2026-07-15 15:30","pubTimestamp":1784100643,"startTime":"0","endTime":"0","summary":"Longeveron ( ($LGVN) ) has provided an update. On July 8, 2026, Longeveron Inc. entered into a revised employment letter agreement with Chief Execu...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/longeveron-enhances-ceo-compensation-and-retention-protections?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/longeveron-enhances-ceo-compensation-and-retention-protections?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651484193","title":"Longeveron Director Arjun JJ Desai Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2651484193","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651484193?lang=en_us&edition=fundamental","pubTime":"2026-07-15 06:00","pubTimestamp":1784066446,"startTime":"0","endTime":"0","summary":"Longeveron director Arjun JJ Desai files initial beneficial ownership statementLongeveron director Arjun JJ Desai filed an initial Form 3 beneficial ownership statement dated July 2, 2026.Disclaimer:T","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDL3lQMqN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651484846","title":"Longeveron CEO Willard Base Salary Rises to $500,000 Under Revised Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2651484846","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651484846?lang=en_us&edition=fundamental","pubTime":"2026-07-15 05:20","pubTimestamp":1784064034,"startTime":"0","endTime":"0","summary":"Longeveron CEO Willard base salary rises to $500,000 under revised agreementLongeveron revised CEO Stephen Willard’s employment letter agreement on July 8, 2026, ending the prior deferral condition on","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260714:nNDLbFLQYj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651142923","title":"Longeveron Files Form 3 for Director Leah Rush Cann","url":"https://stock-news.laohu8.com/highlight/detail?id=2651142923","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651142923?lang=en_us&edition=fundamental","pubTime":"2026-07-14 06:00","pubTimestamp":1783980046,"startTime":"0","endTime":"0","summary":"Longeveron files Form 3 for director Leah Rush CannLongeveron director Cann Leah Rush filed an initial Form 3 disclosure dated July 1, 2026.Disclaimer:This news brief was created by Public Technologie","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL2bGfmS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651611529","title":"Longeveron Says Stem Cell Therapy Laromestrocel Reduces Neuroinflammation in Phase 2a Mild Alzheimer’s Trial Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2651611529","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651611529?lang=en_us&edition=fundamental","pubTime":"2026-07-13 19:06","pubTimestamp":1783940802,"startTime":"0","endTime":"0","summary":"Longeveron says stem cell therapy laromestrocel reduces neuroinflammation in Phase 2a mild Alzheimer’s trial analysisLongeveron disclosed additional Phase 2a CLEAR-MIND analyses showing laromestrocel ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260713:nNDL3Hj0xf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","BK4112","IE00BN0W2V16.EUR","LU2210149790.SGD","NDAQ","BK4585","BK4588","IE00BGHQF748.EUR","BK4139","IE00B3QW5Z07.USD","IE00BKPKM429.USD","LGVN","IE00B64PRP62.GBP","SG9999014013.SGD","SG9999014005.SGD","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","SG9999014021.USD","LU0314104364.USD","LU2095319765.USD","BCDF","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650937916","title":"Longeveron grants special equity awards to Executive Chairman","url":"https://stock-news.laohu8.com/highlight/detail?id=2650937916","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650937916?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:31","pubTimestamp":1783542705,"startTime":"0","endTime":"0","summary":"Longeveron ( ($LGVN) ) has shared an announcement. On July 6, 2026, Longeveron, Inc. granted special equity awards to its Executive Chairman under ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/longeveron-grants-special-equity-awards-to-executive-chairman?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/longeveron-grants-special-equity-awards-to-executive-chairman?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650915148","title":"Longeveron Grants Executive Chairman 1 Million Special Equity Awards Tied to Financing, Continued Service","url":"https://stock-news.laohu8.com/highlight/detail?id=2650915148","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650915148?lang=en_us&edition=fundamental","pubTime":"2026-07-09 04:09","pubTimestamp":1783541355,"startTime":"0","endTime":"0","summary":"Longeveron grants executive chairman 1 million special equity awards tied to financing, continued serviceLongeveron issued special equity awards to its executive chairman on July 6, 2026 under its ame","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDL6XHPjC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649674514","title":"Longeveron strengthens financial leadership with new CFO appointment","url":"https://stock-news.laohu8.com/highlight/detail?id=2649674514","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649674514?lang=en_us&edition=fundamental","pubTime":"2026-07-07 05:27","pubTimestamp":1783373260,"startTime":"0","endTime":"0","summary":"Longeveron ( ($LGVN) ) has issued an update. Longeveron Inc., a clinical-stage biotech focused on stem cell-based regenerative therapies for rare p...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/longeveron-strengthens-financial-leadership-with-new-cfo-appointment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/longeveron-strengthens-financial-leadership-with-new-cfo-appointment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649051679","title":"Longeveron appoints Marie Washburn CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2649051679","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649051679?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:10","pubTimestamp":1783368628,"startTime":"0","endTime":"0","summary":"Longeveron (LGVN) announced that the company has appointed Marie Washburn to the company’s executive leadership team in the role of senior VP and C...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/longeveron-appoints-marie-washburn-cfo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/longeveron-appoints-marie-washburn-cfo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679102","title":"Longeveron Names Marie Washburn CFO, Replacing Lisa Locklear","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679102","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679102?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:09","pubTimestamp":1783368543,"startTime":"0","endTime":"0","summary":"Longeveron names Marie Washburn CFO, replacing Lisa LocklearLongeveron named Marie Washburn senior vice president, chief financial officer, principal financial officer, principal accounting officer, e","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL4PPKp1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2403377893.USD","BMED","FHLC","IHE","IE0000B7K699.USD","IE00BLSP4452.SGD","LU0098860793.USD","LU0545562505.USD","LU2347655156.SGD","PJP","LU1732799900.SGD","LU0124676726.USD","LU1145028129.USD","LU0820561818.USD","LU1162221912.USD","LU1506573853.SGD","LU1778281490.HKD","SG9999001440.SGD","LU1221951046.USD","JDOC","IE0002270589.USD","LU1914381329.SGD","IYH","LGVN","LU0210536198.USD","LU1935042991.SGD","IE00BFTCPJ56.SGD","IE000WAW04H5.SGD","LU0689472784.USD","BK4559","LU0943347566.SGD","LU2592432038.USD","VHT","MEDX","GDOC","IXJ","FTXH","LU1244550221.USD","XLV","RXL","LU0683600562.USD","JNJ","LU1196500208.SGD","LU1718418525.SGD","LU0070217475.USD","LU1894683264.USD","LU1267930813.SGD","LU2129689605.HKD","IE00B19Z3581.USD","LU2756315318.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649913679","title":"Longeveron® Appoints Marie Washburn as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2649913679","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649913679?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:05","pubTimestamp":1783368301,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUA8FBGZQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649679918","title":"Longeveron - Marie Washburn Succeeds Lisa Locklear as CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2649679918","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649679918?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:05","pubTimestamp":1783368301,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nTUA8FBGZQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LGVN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649799206","title":"Press Release: Longeveron(r) Appoints Marie Washburn as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2649799206","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649799206?lang=en_us&edition=fundamental","pubTime":"2026-07-07 04:05","pubTimestamp":1783368300,"startTime":"0","endTime":"0","summary":"-- Ms. Washburn has over 20 years of experience in leadership roles in the. -- Corporate focus on delivering top-line results from the Phase 2b clinical. trial evaluating its stem cell therapy in Hypoplastic Left Heart Syndrome","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MSC","BK4575","BK4022","SYNB","R","EMM","BK4150","BK4588","BK4232","IBB","BK4585","LGVN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644086763","title":"Longeveron says new Phase 2a analysis of laromestrocel in mild Alzheimer’s accepted for AAIC 2026 poster presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2644086763","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644086763?lang=en_us&edition=fundamental","pubTime":"2026-06-18 21:20","pubTimestamp":1781788821,"startTime":"0","endTime":"0","summary":"Longeveron flagged an additional analysis from its Phase 2a CLEAR MIND study of laromestrocel in mild Alzheimer’s disease.Results were already published in Nature Medicine in March 2025, supporting potential benefit and backing continued clinical development.The new analysis will be presented at the 2026 Alzheimer’s Association International Conference in London on July 13.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nNDL7RjP7p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU2210149790.SGD","BK4112","IE00BN0W2V16.EUR","BK4588","IE00BN0W2W23.USD","IE00B3QW5Z07.USD","BK4585","SG9999014013.SGD","SG9999014021.USD","IE00B64PRP62.GBP","IE00BKPKM429.USD","SG9999014039.USD","LU2210150020.SGD","LGVN","LU0314104364.USD","NDAQ","IE00BN0W2T93.GBP","BK4139","SG9999014005.SGD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.longeveron.com","stockEarnings":[{"period":"1week","weight":0.0919},{"period":"1month","weight":0.1913},{"period":"3month","weight":-0.0937},{"period":"6month","weight":0.4932},{"period":"1year","weight":-0.3969},{"period":"ytd","weight":0.5138}],"compareEarnings":[{"period":"1week","weight":0.0351},{"period":"1month","weight":0.0374},{"period":"3month","weight":0.0483},{"period":"6month","weight":0.1197},{"period":"1year","weight":0.223},{"period":"ytd","weight":0.1339}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States and Japan. The company's lead investigational product is the LOMECEL-B, a candidate in Phase 2a/b trials that is used for the treatment of alzheimer's disease, hypoplastic left heart syndrome, and aging-related frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.146765},{"month":2,"riseRate":0,"avgChangeRate":-0.052773},{"month":3,"riseRate":0.5,"avgChangeRate":0.193379},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.138428},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.132971},{"month":6,"riseRate":0.666667,"avgChangeRate":0.086991},{"month":7,"riseRate":0.5,"avgChangeRate":0.154004},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.259187},{"month":9,"riseRate":0.2,"avgChangeRate":-0.104571},{"month":10,"riseRate":0.4,"avgChangeRate":-0.0027},{"month":11,"riseRate":0.4,"avgChangeRate":1.29104},{"month":12,"riseRate":0,"avgChangeRate":-0.282059}],"exchange":"NASDAQ","name":"Longeveron Inc","nameEN":"Longeveron Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Longeveron Inc(LGVN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Longeveron Inc(LGVN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Longeveron Inc,LGVN,Longeveron Inc股票,Longeveron Inc股票老虎,Longeveron Inc股票老虎国际,Longeveron Inc行情,Longeveron Inc股票行情,Longeveron Inc股价,Longeveron Inc股市,Longeveron Inc股票价格,Longeveron Inc股票交易,Longeveron Inc股票购买,Longeveron Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Longeveron Inc(LGVN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Longeveron Inc(LGVN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction